Biotech Values

[turtlepower]

Thanks for the link. None of the candidates from the table appear to be in development according to information on clintrials.gov and the companies websites. AZN, Roche and Lilly appear to be focusing mostly on SGLT2 inhibitors and DPP4 inhibitors.

I get 6 results when i search for glucokinase on clintrials.gov.
Searching for SLGT2 returns 19 results and DPP4 505 results.